Bicycle Therapeutics (BCYC) Revenue (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Revenue of $887000.0 for Q1 2026, down 98.15% on a QoQ basis from $48.0 million in Q4 2025, and down 91.11% year-over-year from $10.0 million in Q1 2025.
Bicycle Therapeutics (BCYC) Revenue (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Revenue history runs 9 years deep, the most recent figure standing at $887000.0 for Q1 2026.
- Quarterly Revenue fell 91.11% year-over-year to $887000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.5 million (up 146.85% YoY) and the FY2025 annual result came in at $72.6 million, up 105.77% from the prior year.
- Revenue was $887000.0 for Q1 2026 at Bicycle Therapeutics, down from $48.0 million in the prior quarter.
- Across five years, Revenue topped out at $48.0 million in Q4 2025 and bottomed at $887000.0 in Q1 2026.
- A 5-year average of $8.7 million and a median of $5.3 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2025 — Revenue jumped 1193.28% — and 2026, when it plunged 91.11%.
- Bicycle Therapeutics' Revenue stood at $8.4 million in 2022, then slumped by 36.54% to $5.3 million in 2023, then slumped by 30.44% to $3.7 million in 2024, then soared by 1193.28% to $48.0 million in 2025, then plunged by 98.15% to $887000.0 in 2026.
- Business Quant data shows BCYC's Revenue at $887000.0 in Q1 2026, $48.0 million in Q4 2025, and $11.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Bicycle Therapeutics | 272.11 Mn | 272.11 Mn | - | 887,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 887,000.00 |
| Dec 31, 2025 | 47.96 Mn |
| Sep 30, 2025 | 11.73 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 9.98 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 9.36 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.35 Mn |
| Jun 30, 2023 | 11.40 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 3.86 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 4.33 Mn |
| Jun 30, 2021 | 1.79 Mn |